Jan 8, 2026 06:30AM

Dec 12, 2025 07:51PM

Nov 24, 2025 07:05AM

Nov 24, 2025 07:00AM

Nov 19, 2025 04:28PM

Nov 19, 2025 04:26PM

Nov 18, 2025 04:44PM NervGen raises US$10 million to support Nasdaq listing and drug development

Nov 18, 2025 04:42PM

Aug 26, 2025 07:30AM

Aug 21, 2025 07:30AM

Jul 17, 2025 07:30AM

Jul 3, 2025 04:41PM

Jul 1, 2025 07:30AM

Jun 18, 2025 07:30AM NervGen Announces Appointment of Randall Kaye, MD to Chief Medical Advisor Role

May 21, 2025 07:30AM

May 15, 2025 07:30AM

May 7, 2025 07:30AM

Apr 21, 2025 07:30AM

Apr 3, 2025 07:30AM

Mar 31, 2025 07:30AM

Mar 25, 2025 08:30AM NervGen Pharma to Host Virtual Investor Event

Mar 5, 2025 08:30AM

Feb 6, 2025 07:30AM

Jan 29, 2025 05:00PM

Jan 2, 2025 07:30AM

Nov 14, 2024 08:30AM

Nov 7, 2024 08:30AM

Sep 30, 2024 08:30AM NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury

Sep 20, 2024 08:30AM

Sep 16, 2024 08:30AM

Aug 27, 2024 08:30AM

Aug 22, 2024 08:30AM

Aug 6, 2024 08:30AM

Jun 20, 2024 08:30AM

Jun 5, 2024 08:30AM NervGen Pharma Announces Results of Annual General Meeting of Shareholders

Jul 28, 2022 10:38AM

Jan 10, 2022 07:30AM

Jul 9, 2019 10:52AM

Jun 10, 2019 07:00AM

324,141 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All